JESSICA MERCHANT: Open Payments
NPI 1023627494 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 27 payments from 21 companies in 2025. Trend: 2023 $191 · 2024 $395 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| GENZYME CORPORATION | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Siemens Medical Solutions USA, Inc. | 1 | $44 |
| Incyte Corporation | 2 | $43 |
| Karyopharm Therapeutics Inc. | 1 | $35 |
| BeOne Medicines USA, Inc. | 1 | $34 |
| TerSera Therapeutics LLC | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: Nubeqa, TrueBeam, XPOVIO, BRUKINSA, Zoladex, EMBLAVEO, Orserdu, ELAHERE.
Industry payments across CA — which companies pay providers there.
